Skip to content
lifestyle.usfeatures.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Boehringer Ingelheim
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
September 17, 2026
Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis
September 1, 2026
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
August 11, 2026
Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.
July 15, 2026
Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers
June 22, 2026